⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ARDX News
Ardelyx, Inc.
Syntis Bio Announces First Patient Dosed in Phase 1/1b Clinical Trial of SYNT-101 in Obesity and Key Leadership Additions
businesswire.com
ARDX
MRNA
Ardelyx and the LPGA Announce Multi-Year Partnership to Break Stigma Around Digestive Health Issues Impacting Millions
globenewswire.com
ARDX
Form 8-K
sec.gov
ARDX
Ardelyx Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
globenewswire.com
ARDX
Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026
globenewswire.com
ARDX
Ardelyx Receives New Patent for Tenapanor
globenewswire.com
ARDX
First Patient Dosed in ACCEL: Phase 3 Chronic Idiopathic Constipation Study of IBSRELA
globenewswire.com
ARDX
Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets
prnewswire.com
ARDX
FATE
MNKD
VRTX
Breaking Barriers: How 2026’s Top Clinical Leaders Are Disrupting Chronic Disease Markets
globenewswire.com
MNKD
VRTX
FATE
ARDX
Ardelyx Reports Preliminary 2025 Revenue and Provides 2026 Strategic Outlook
globenewswire.com
ARDX